Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone

Treatment of cancer metastasized to bone is still a challenge due to hydrophobicity, instability, and lack of target specificity of anticancer drugs. Poly (ethylene glycol)-poly (ε-caprolactone) polymer (PEG-PCL) is an effective, biodegradable, and biocompatible hydrophobic drug carrier, but lacks b...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinsong, Zeng, Youyun, Shi, Shuai, Xu, Lihua, Zhang, Hualin, Pathak, Janak L, Pan, Yihuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428813/
https://www.ncbi.nlm.nih.gov/pubmed/28507436
http://dx.doi.org/10.2147/IJN.S133787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428813/
https://www.ncbi.nlm.nih.gov/pubmed/28507436
http://dx.doi.org/10.2147/IJN.S133787

Ejemplares similares